Bernstein cuts Coupang stock price target on growth concerns By Investing.com

Bernstein SocGen cut Coupang’s price target to $15 from $17 and lowered its 2026 EPS estimate to a $0.13 loss from a $0.03 loss, while trimming 2027 EPS by 11%. The firm cited softer top-line growth, operating deleverage, and intensifying competition that could compress margins, though DCF assumptions were unchanged. Separately, Coupang’s Q1 2026 results showed an EPS miss of -$0.15 vs -$0.03 expected, partially offset by revenue of $8.5B versus $8.49B consensus.

Analysis

The key signal is not the downgrade itself but the implication that growth is decelerating faster than management can lever fixed costs. For a marketplace/retail model, that combination is dangerous because it tends to compress margins twice: first through lower incremental take-rate, then through higher fulfillment and promo intensity to defend engagement. The market is still pricing Coupang like a long-duration growth compounder, but this note argues the reinvestment phase is extending, which pushes meaningful free-cash-flow inflection further out.

Second-order, weaker Coupang economics can spill into the broader Korea internet/consumer stack by raising the cost of customer acquisition and making cross-sell economics less reliable. If competitors are partnering rather than purely spending, the industry can shift from a war of subsidies to a war of ecosystem bundling, which is harder for a standalone retailer to defend against. That increases the odds that management responds by leaning harder into Taiwan and delivery/food initiatives, but those projects likely act as cash drains before they create any valuation support.

The consensus gap is that the debate is still anchored on revenue beats versus earnings misses, when the more important variable is whether current share gains are coming from uneconomic traffic. If top-line growth remains merely mid-to-high single digits, the market will eventually re-rate the stock off a slower terminal margin structure rather than near-term EPS volatility. In that regime, the downside is less about one bad quarter and more about multiple compression over the next 3-6 months if margin guidance keeps being revised down.

Key Decisions for Investors

• Maintain/enter a tactical short CPNG into any post-note strength; use a 1-3 month horizon with a stop on a sustained re-acceleration in top-line growth or gross margin stabilization. Risk/reward favors downside because the name still trades on a growth premium while earnings revisions are moving lower.
• Pair trade: long KWEB/IGV-adjacent large-cap platform exposure, short CPNG, to isolate idiosyncratic margin-risk in a business where competitive intensity is rising. This works best over 1-2 quarters if Korea consumer internet multiples hold but Coupang revisions continue to cut through the group.
• For options, buy 3-4 month put spreads on CPNG rather than outright puts to reduce theta in a name with elevated event risk. Structure around earnings/guidance windows where another margin revision could trigger a fast re-rating.
• If holding a long from lower levels, trim into rallies until the market gets evidence of operating leverage returning; only add back on clear signs that CAC and fulfillment expense ratios are peaking. The current setup is a 'prove it' trade, not a momentum trade.